Skip to main content
SpringerLink
Log in
Book cover

Antiepileptic Drug Interactions pp 141–144Cite as

Vigabatrin

  • Chapter
  • First Online:

  • 1059 Accesses

Abstract

The pharmacokinetic characteristics of vigabatrin are described and the interaction effects of concomitant antiepileptic drugs on vigabatrin in terms of its pharmacokinetics and pharmacodynamics are highlighted.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Armijo JA, Cuadrado A, Bravo J, Arteaga R. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs. Ther Drug Monit. 1997;19:491–8.

    Article  CAS  PubMed  Google Scholar 

  2. Brodie MJ, Mumford JP. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group. Epilepsy Res. 1999;34:199–205.

    Article  CAS  PubMed  Google Scholar 

  3. Reidenberg P, Glue P, Banfield C, Colucci R, Meehan J, Rey E, Radwanski E, Nomeir A, Lim J, Lin C, Guillaume M, Affrime MB. Pharmacokinetic interaction studies between felbamate and vigabatrin. Br J Clin Pharmacol. 1995;40:157–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Stolarek I, Blacklaw J, Forrest G, Brodie MJ. Vigabatrin and lamotrigine in refractory epilepsy. J Neurol Neurosurg Psychiatry. 1994;57:921–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Perucca E, Baltes E, Ledent E. Levetiracetam: absence of pharmacokinetic interactions with other antiepileptic drugs (AEDs). Epilepsia. 2000;41(Suppl 6):150.

    Google Scholar 

  6. Spence SJ, Nakagawa J, Sankar R, Shields WD. Phenobarbital interferes with the efficacy of vigabatrin in treating infantile spasms in patients with tuberous sclerosis. Epilepsia. 2000;41 (Suppl 7):189.

    Google Scholar 

  7. Leach JP, Brodie MJ. Synergism with GABAergic drugs in refractory epilepsy. Lancet. 1994;343:1650.

    Article  CAS  PubMed  Google Scholar 

  8. Armijo JA, Arteaga R, Valdizan EM, Herranz JL. Coadministration of vigabatrin and valproate in children with refractory epilepsy. Clin Neuropharmacol. 1992;15:459–69.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Therapeutic Drug Monitoring Unit Department of Clinical and Experimental Epilepsy, UCL-Institute of Neurology, Queen Square, London, UK

    Philip N. Patsalos

  2. Chalfont Centre for Epilepsy Chalfont St Peter, Buckinghamshire, UK

    Philip N. Patsalos

Authors
  1. Philip N. Patsalos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Patsalos, P.N. (2016). Vigabatrin. In: Antiepileptic Drug Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-32909-3_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32909-3_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32908-6

  • Online ISBN: 978-3-319-32909-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation